These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
147 related articles for article (PubMed ID: 8575195)
1. The role of CD4 in HIV envelope-mediated pathogenesis. Siliciano RF Curr Top Microbiol Immunol; 1996; 205():159-79. PubMed ID: 8575195 [TBL] [Abstract][Full Text] [Related]
2. Surface expression of the HIV-1 envelope proteins in env gene-transfected CD4-positive human T cell clones: characterization and killing by an antibody-dependent cellular cytotoxic mechanism. Ahmad A; Yao XA; Tanner JE; Cohen E; Menezes J J Acquir Immune Defic Syndr (1988); 1994 Aug; 7(8):789-98. PubMed ID: 7912729 [TBL] [Abstract][Full Text] [Related]
3. Analysis of endoproteolytic cleavage and intracellular transport of human immunodeficiency virus type 1 envelope glycoproteins using mutant CD4 molecules bearing the transmembrane endoplasmic reticulum retention signal. Raja NU; Vincent MJ; Jabbar MA J Gen Virol; 1993 Oct; 74 ( Pt 10)():2085-97. PubMed ID: 8409933 [TBL] [Abstract][Full Text] [Related]
4. Activation and Inactivation of Primary Human Immunodeficiency Virus Envelope Glycoprotein Trimers by CD4-Mimetic Compounds. Madani N; Princiotto AM; Zhao C; Jahanbakhshsefidi F; Mertens M; Herschhorn A; Melillo B; Smith AB; Sodroski J J Virol; 2017 Feb; 91(3):. PubMed ID: 27881646 [TBL] [Abstract][Full Text] [Related]
5. Enzyme immunoassay (ELISA) for the evaluation of antibodies directed to the CD4 receptor-binding site of the HIV gp120 molecule. Hinkula J; Gidlund M; Persson C; Osterhaus A; Wahren B J Immunol Methods; 1994 Sep; 175(1):37-46. PubMed ID: 7523525 [TBL] [Abstract][Full Text] [Related]
6. Vaccinia virus vectors for study of membrane fusion mediated by human immunodeficiency virus envelope glycoprotein and CD4. Ashorn P; Berger EA; Moss B Methods Enzymol; 1993; 221():12-8. PubMed ID: 8361369 [No Abstract] [Full Text] [Related]
7. Improbability of harmful autoimmune responses resulting from immunization with HIV-1 envelope glycoproteins. Neurath AR; Strick N; Li YY; Jiang S AIDS Res Hum Retroviruses; 1993 Dec; 9(12):1195-208. PubMed ID: 8142138 [TBL] [Abstract][Full Text] [Related]
8. Normal T cell receptor-mediated signaling in T cell lines stably expressing HIV-1 envelope glycoproteins. Tani Y; Tian H; Lane HC; Cohen DI J Immunol; 1993 Dec; 151(12):7337-48. PubMed ID: 7903106 [TBL] [Abstract][Full Text] [Related]
9. Cross-linking of CD4 molecules upregulates Fas antigen expression in lymphocytes by inducing interferon-gamma and tumor necrosis factor-alpha secretion. Oyaizu N; McCloskey TW; Than S; Hu R; Kalyanaraman VS; Pahwa S Blood; 1994 Oct; 84(8):2622-31. PubMed ID: 7522637 [TBL] [Abstract][Full Text] [Related]
10. Membrane expression of HIV envelope glycoproteins triggers apoptosis in CD4 cells. Laurent-Crawford AG; Krust B; Rivière Y; Desgranges C; Muller S; Kieny MP; Dauguet C; Hovanessian AG AIDS Res Hum Retroviruses; 1993 Aug; 9(8):761-73. PubMed ID: 8105835 [TBL] [Abstract][Full Text] [Related]
11. Human immunodeficiency virus type-1 envelope glycoprotein gp120 induces expression of fusion regulatory protein (FRP)-1/CD98 on CD4+ T cells: a possible regulatory mechanism of HIV-induced syncytium formation. Suga S; Tsurudome M; Ito M; Ohgimoto S; Tabata N; Nishio M; Kawano M; Komada H; Ito M; Sakurai M; Ito Y Med Microbiol Immunol; 1997 Mar; 185(4):237-43. PubMed ID: 9138296 [TBL] [Abstract][Full Text] [Related]
12. A monoclonal antibody to the gp120-CD4 complex has differential effect on HIV-induced syncytium formation and viral infectivity. Konopka K; Pretzer E; Celada F; Düzgüneş N J Gen Virol; 1995 Mar; 76 ( Pt 3)():669-79. PubMed ID: 7897355 [TBL] [Abstract][Full Text] [Related]
13. Biological properties of recombinant HIV envelope synthesized in CHO glycosylation-mutant cell lines. Fenouillet E; Miquelis R; Drillien R Virology; 1996 Apr; 218(1):224-31. PubMed ID: 8615025 [TBL] [Abstract][Full Text] [Related]
14. Membrane-interactive phospholipids inhibit HIV type 1-induced cell fusion and surface gp160/gp120 binding to monoclonal antibody. Krugner-Higby L; Goff D; Edwards T; Iyer N; Neufeld J; Kute T; Morris-Natschke S; Ishaq K; Piantadosi C; Kucera LS AIDS Res Hum Retroviruses; 1995 Jun; 11(6):705-12. PubMed ID: 7576930 [TBL] [Abstract][Full Text] [Related]
15. Cross-Linking of a CD4-Mimetic Miniprotein with HIV-1 Env gp140 Alters Kinetics and Specificities of Antibody Responses against HIV-1 Env in Macaques. Shen X; Bogers WM; Yates NL; Ferrari G; Dey AK; Williams WT; Jaeger FH; Wiehe K; Sawant S; Alam SM; LaBranche CC; Montefiori DC; Martin L; Srivastava I; Heeney J; Barnett SW; Tomaras GD J Virol; 2017 Oct; 91(19):. PubMed ID: 28490585 [TBL] [Abstract][Full Text] [Related]
16. Adhesion mediated by intercellular adhesion molecule 1 attenuates the potency of antibodies that block HIV-1 gp160-dependent syncytium formation. Berman PW; Nakamura GR AIDS Res Hum Retroviruses; 1994 May; 10(5):585-93. PubMed ID: 7917519 [TBL] [Abstract][Full Text] [Related]
17. Development of T-cell lines expressing functional HIV-1 envelope glycoproteins for evaluation of immune responses in HIV-infected individuals. Keler T; Li H; Cloyd MW; Vitale LA; Deo YM J Acquir Immune Defic Syndr Hum Retrovirol; 1996 Oct; 13(2):117-26. PubMed ID: 8862276 [TBL] [Abstract][Full Text] [Related]
18. The difference in gp160 and gp120 of HIV type 1 in the induction of CD4 downregulation preceding single-cell killing. Koga Y; Nakamura K; Sasaki M; Kimura G; Nomoto K Virology; 1994 May; 201(1):137-41. PubMed ID: 8178478 [TBL] [Abstract][Full Text] [Related]
19. Generation of lymphocyte cell lines coexpressing CD4 and wild-type or mutant HIV type 1 glycoproteins: implications for HIV type 1 Env-induced cell lysis. Krüger U; Pfeiffer T; Bosch V AIDS Res Hum Retroviruses; 1996 Jun; 12(9):783-92. PubMed ID: 8738430 [TBL] [Abstract][Full Text] [Related]
20. HIV-1 R5 Macrophage-Tropic Envelope Glycoprotein Trimers Bind CD4 with High Affinity, while the CD4 Binding Site on Non-macrophage-tropic, T-Tropic R5 Envelopes Is Occluded. Quitadamo B; Peters PJ; Repik A; O'Connell O; Mou Z; Koch M; Somasundaran M; Brody R; Luzuriaga K; Wallace A; Wang S; Lu S; McCauley S; Luban J; Duenas-Decamp M; Gonzalez-Perez MP; Clapham PR J Virol; 2018 Jan; 92(2):. PubMed ID: 29118121 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]